Nuo Therapeutics, Inc. (AURX)

Capital Expenditure

-$253.03K

Quarterly · Period ending: · USD

AURX logo

AURX Capital Expenditure

Latest reported-$253.03K
AURX Quarterly CapEx (-$144.20K → -$253.03K)
High-resolution chart · PNG

AURX capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-253,027
-847
-43,205
-4
-1,667
-229,884
0
-150,862
-4,100
0
0
-1,901
0
-5,343
-4,649
-3,808
-39,687
-11,848
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
532,355
0
0
0
-427,355
-105,000
0
-165,817
-273,500
-133,249
-480
-75,733
-150,324
-313,322
-187,051
-100,000
-351,433
-734,004
-726,307
-275,818
-64,869
0
0
-1,561
-745,299
47,087
0
0
31,424
-3,950
0
-27,474
-16,491
-54,980
-2,352
-13,190
0
0
0
0
0
0
0
0
0
0
0
0
-25,418
-22,345
-6,758
-2,042
0
-11,653
0
0
-177,709
-98,438
-22,124
-6,600
0
0
0
-38,883
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.